Illumina (ILMN) Competitors $87.54 -0.44 (-0.50%) Closing price 04:00 PM EasternExtended Trading$87.88 +0.33 (+0.38%) As of 06:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ILMN vs. A, MTD, WAT, TECH, CRL, BIO, BRKR, PACB, HBIO, and TMOShould you be buying Illumina stock or one of its competitors? The main competitors of Illumina include Agilent Technologies (A), Mettler-Toledo International (MTD), Waters (WAT), Bio-Techne (TECH), Charles River Laboratories International (CRL), Bio-Rad Laboratories (BIO), Bruker (BRKR), Pacific Biosciences of California (PACB), Harvard Bioscience (HBIO), and Thermo Fisher Scientific (TMO). These companies are all part of the "life sciences tools & services" industry. Illumina vs. Its Competitors Agilent Technologies Mettler-Toledo International Waters Bio-Techne Charles River Laboratories International Bio-Rad Laboratories Bruker Pacific Biosciences of California Harvard Bioscience Thermo Fisher Scientific Illumina (NASDAQ:ILMN) and Agilent Technologies (NYSE:A) are both large-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, media sentiment, profitability, analyst recommendations, institutional ownership, earnings, dividends, risk and community ranking. Do analysts recommend ILMN or A? Illumina presently has a consensus target price of $126.94, suggesting a potential upside of 43.40%. Agilent Technologies has a consensus target price of $140.15, suggesting a potential upside of 15.95%. Given Illumina's higher probable upside, equities research analysts clearly believe Illumina is more favorable than Agilent Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Illumina 1 Sell rating(s) 9 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 2.47Agilent Technologies 0 Sell rating(s) 7 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.50 Which has more volatility & risk, ILMN or A? Illumina has a beta of 1.32, meaning that its stock price is 32% more volatile than the S&P 500. Comparatively, Agilent Technologies has a beta of 1.23, meaning that its stock price is 23% more volatile than the S&P 500. Do institutionals and insiders believe in ILMN or A? 89.4% of Illumina shares are held by institutional investors. 2.6% of Illumina shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Does the media prefer ILMN or A? In the previous week, Illumina had 6 more articles in the media than Agilent Technologies. MarketBeat recorded 16 mentions for Illumina and 10 mentions for Agilent Technologies. Illumina's average media sentiment score of 1.42 beat Agilent Technologies' score of 1.23 indicating that Illumina is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Illumina 8 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Agilent Technologies 9 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is ILMN or A more profitable? Agilent Technologies has a net margin of 17.59% compared to Illumina's net margin of -27.95%. Agilent Technologies' return on equity of 25.92% beat Illumina's return on equity.Company Net Margins Return on Equity Return on Assets Illumina-27.95% 13.37% 5.49% Agilent Technologies 17.59%25.92%13.24% Does the MarketBeat Community prefer ILMN or A? Illumina received 245 more outperform votes than Agilent Technologies when rated by MarketBeat users. However, 71.04% of users gave Agilent Technologies an outperform vote while only 65.15% of users gave Illumina an outperform vote. CompanyUnderperformOutperformIlluminaOutperform Votes111665.15% Underperform Votes59734.85% Agilent TechnologiesOutperform Votes87171.04% Underperform Votes35528.96% Which has higher valuation & earnings, ILMN or A? Agilent Technologies has higher revenue and earnings than Illumina. Illumina is trading at a lower price-to-earnings ratio than Agilent Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIllumina$4.34B3.23-$1.22B-$6.07-14.58Agilent Technologies$6.51B5.27$1.29B$4.0529.84 SummaryAgilent Technologies beats Illumina on 10 of the 19 factors compared between the two stocks. Get Illumina News Delivered to You Automatically Sign up to receive the latest news and ratings for ILMN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ILMN vs. The Competition Export to ExcelMetricIlluminaAnalytical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$14.01B$4.61B$5.60B$8.65BDividend YieldN/A0.56%5.27%4.19%P/E Ratio-11.5225.2327.3320.13Price / Sales3.233.93412.21156.99Price / Cash20.7236.2838.2534.64Price / Book5.911.697.154.74Net Income-$1.22B-$82.28M$3.23B$247.88M7 Day Performance6.45%5.64%3.49%2.64%1 Month Performance16.85%16.40%12.92%9.95%1 Year Performance-21.38%-9.45%32.15%15.33% Illumina Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ILMNIllumina4.9128 of 5 stars$87.54-0.5%$126.94+45.0%-19.9%$13.86B$4.34B-11.4011,500Positive NewsAnalyst ForecastOptions VolumeAAgilent Technologies4.6351 of 5 stars$116.77+0.8%$140.15+20.0%-9.3%$33.17B$6.51B28.8317,900Positive NewsMTDMettler-Toledo International3.6973 of 5 stars$1,196.53+1.0%$1,302.11+8.8%-15.6%$24.87B$3.83B29.5218,000Positive NewsWATWaters4.0963 of 5 stars$348.56-0.7%$390.19+11.9%+16.1%$20.74B$2.98B32.558,200TECHBio-Techne4.868 of 5 stars$49.88+2.4%$72.00+44.3%-33.3%$7.82B$1.21B50.383,000Analyst DowngradeCRLCharles River Laboratories International4.7485 of 5 stars$147.51+1.9%$171.85+16.5%-29.6%$7.25B$4.02B983.4321,400BIOBio-Rad Laboratories4.8016 of 5 stars$225.84+2.9%$324.25+43.6%-19.0%$6.15B$2.54B-3.478,200Analyst DowngradeAnalyst RevisionBRKRBruker4.9382 of 5 stars$39.19+2.3%$56.22+43.5%-37.4%$5.94B$3.45B51.568,520Insider TradePACBPacific Biosciences of California1.595 of 5 stars$1.21+5.7%$2.13+76.9%-38.6%$361.60M$152.36M-0.73730Positive NewsHBIOHarvard Bioscience3.8904 of 5 stars$0.56+36.2%$3.00+438.6%-78.8%$24.63M$91.40M-1.69490Trending NewsShort Interest ↑Gap UpHigh Trading VolumeTMOThermo Fisher Scientific4.9806 of 5 stars$408.57+1.7%$605.30+48.2%-28.7%$154.23B$42.90B24.72130,000Positive News Related Companies and Tools Related Companies Agilent Technologies Alternatives Mettler-Toledo International Alternatives Waters Alternatives Bio-Techne Alternatives Charles River Laboratories International Alternatives Bio-Rad Laboratories Alternatives Bruker Alternatives Pacific Biosciences of California Alternatives Harvard Bioscience Alternatives Thermo Fisher Scientific Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ILMN) was last updated on 6/11/2025 by MarketBeat.com Staff From Our PartnersElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Illumina, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Illumina With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.